Beside COL6 ability to modulate the PI3K/AKT pathway in cancer, in vivo and in vitro studies demonstrated an impact of COL6 on such axis in other districts, with also deregulation of MAPK/ERK kinases and upregulation of mTOR in the COL6 knockout context [21, 77]. This evidence concerns the gene MTOR and cancer.